Search for: "PFIZER" Results 1361 - 1380 of 4,632
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Aug 2016, 2:33 pm by Schachtman
Applying a robust interpretation of Pennsylvania’s Frye rule, Judge Bernstein excluded Freeman and Cabrera’s proffered testimony, and entered summary judgment for defendant Pfizer, Inc. [read post]
25 Aug 2016, 1:52 pm by Ahmed Shehata
The Industrials & Chemicals sector lead the way with US$244bn in transaction value and 1486 deals, despite New Treasury rules aimed at dissuading tax inversions leading to the termination of the US$183.7bn Pfizer and Allergan transaction. [read post]
24 Aug 2016, 4:12 am by Rose Walker, staff
US firms win mandates to advise on Pfizer's latest acquisition of part of a UK antibiotics business [read post]
22 Aug 2016, 12:53 pm by Tom Lamb
To overcome that headwind and broaden the use of their drugs, Johnson & Johnson, Bristol-Myers Squibb, and Pfizer provided funding to Portola Pharmaceuticals so it could develop AndexXa. [read post]
17 Aug 2016, 10:38 am by Kelly Phillips Erb
Pfizer repatriated the most money under the 2004 holiday and received criticism for subsequently laying off 3,500 U.S. employees the following year. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
5 Aug 2016, 4:00 am by LindaMBeale
See Michael Merced and Leslie Picker, Pfizer and Allergan Are Said to End Merger as Tax Rules Tighten, NY Times (Apr. 5, 2016). [read post]
5 Aug 2016, 4:00 am by LindaMBeale
See Michael Merced and Leslie Picker, Pfizer and Allergan Are Said to End Merger as Tax Rules Tighten, NY Times (Apr. 5, 2016). [read post]
6 Jul 2016, 1:40 pm by Tom Lamb
On the legal front, a growing number of Viagra - melanoma lawsuits have been filed against the drug company Pfizer. [read post]
30 Jun 2016, 12:12 pm by Tom Lamb
Non-clinical studies have demonstrated reversal of all approved NOACs including Daiichi Sankyo's SavaysaTM/Lixiana® (edoxaban), Boehringer Ingelheim's Pradaxa® (dabigatran etexilate), Johnson & Johnson and Bayer's Xarelto® (rivaroxaban), and Bristol-Myers Squibb and Pfizer's Eliquis® (apixaban). [read post]
21 Jun 2016, 4:00 am by Paula Bremner
The Federal Court of Appeal has not squarely addressed the discrete disclosure issue since the SCC arguably “reinvigorated” the debate in Pfizer v Novopharm (“Viagra SCC”)[3], but may address the matter over the next year in Idenix’s pending appeal regarding the hepatitis drug sofosbuvir.[4] There appear to be some inconsistencies in recent FCA decisions. [read post]
8 Jun 2016, 8:59 am by Eric Needs
The FDA isThe post FDA Says Pfizer Opioid Meant to Deter Abuse Has Tampering Risk appeared first on Legal Reader. [read post]
6 Jun 2016, 12:21 pm by Tom Kosakowski
Shore, Vice President and Chief Ombudsman, CO-OP®, Office of the Ombudsman, Pfizer Inc.; Joan Waters, University Ombuds Officer, Columbia University; James Hurst, Agency Staff Attorney, NYC Department of Consumer Affairs; Nancy Deering, Newark Public Schools and IOAProgram Description: Explore the impact of the ombuds role in advancing conflict resolution and ADR. [read post]